Inflammatory bowel diseases
Exercise in patients with inflammatory bowel diseases: current perspectives
... Abstract: Inflammatory bowel diseases (IBDs), including both Crohn’s disease (CD) and ulcerative colitis (UC), are chronic autoimmune diseases. Both CD and UC have relapsing and remitting ...
11
Association between Serum 25 (OH) Vitamin D Concentrations and Inflammatory Bowel Diseases (IBDs) Activity
... Inflammatory bowel diseases (IBDs) are immune mediated diseases affecting the gastrointestinal ...autoimmune diseases is vitamin D (VitD) ...
5
Is-there a place for vagus nerve stimulation in inflammatory bowel diseases?
... many diseases and has a pro-inflammatory role. Inflammatory bowel diseases (IBD) are chronic disorders of the gastro-intestinal tract where TNF α is a key ...
9
The microbial basis of inflammatory bowel diseases
... The assemblage of gut microbes throughout life is not stochas- tic, but determined by a combination of host, microbial (i.e., self-selective), and environmental factors. Genome-wide associ- ation studies (GWASs) provided ...
8
Human Development Index and Inflammatory Bowel Diseases
... Although the reasons for such increase in Developing Countries have not been convincingly described, the process of industrialization and pollution seems to have some influence in the incidence, since environmental ...
8
Colorectal carcinoma in the course of inflammatory bowel diseases
... 8-OHdG: 8-hydroxydeoxyguanosine; APC: Adenomatous polyposis coli; CAC: Colitis - associated colorectal cancer; CD: Crohn ’ s disease; CIN: Chromosomal instability; COX-2: Cyclooxygenase 2; CRC: Colorectal cancer; DCC: ...
9
Value-Based Health Care for Inflammatory Bowel Diseases
... changes. Inflammatory bowel diseases rank among the most costly of chronic diseases, and physicians nowadays are increasingly engaged in health economics ...on inflammatory bowel ...
7
Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
... of diseases, including liver disease and inflammatory bowel ...to inflammatory cytokines, by producing immunoregulatory factors that modulate the progression of inflammation by affecting ...
15
MYO9B gene polymorphisms are associated with the risk of inflammatory bowel diseases
... Myosin IXB (MYO9B) gene polymorphisms have been extensively investigated in terms of their associations with inflammatory bowel disease (IBD), with contradictory results. The aim of this meta-analysis was ...
14
Differential patterns of histone acetylation in inflammatory bowel diseases
... Human tissue was collected during routine surgery, or routine endoscopy procedures at St. Thomas ’ hospital with appropriate ethical approval. Biopsies were col- lected from 12 patients aged between 18-57 yrs with Crohn ...
12
A role for proteinase activated receptor–1 in inflammatory bowel diseases
... scoring inflammatory parameters such as erythema, hemorrhage, edema, stricture formation, ulceration, presence of blood in the feces, mucus presence, diarrhea, and ...
14
<p>Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases</p>
... Introduction: The better understanding of the molecular mechanisms, which drive the pathological process in the gut of patients with Crohn ’ s disease (CD) and patients with ulcerative colitis (UC), the major forms of in ...
5
Thromboembolism in inflammatory bowel diseases: a report from Saudi Arabia
... he developed enterovesical fistula and was started on antitumor necrosis factor (TNF) (infliximab). He received four cycles with partial improvement and then was lost for follow-up. He presented to our hospital with a ...
7
Early life environment and natural history of inflammatory bowel diseases
... with Clostridium difficile , Bacteroides , and Lactobacilli and higher frequency of the protective bifidobacteria [30]. Other studies demonstrated similar changes in the enteric microbiome of breastfed infants [31,32]. ...
6
Defects in Macrophage Specific Homeostatic Pathways in the Inflammatory Bowel Diseases
... these inflammatory conditions, the close proximity of subepithelial macrophages to the intestinal microbiota thus results in a constant, excessive activation of the mucosal innate immune system ...
181
Biologic targeting in the treatment of inflammatory bowel diseases
... With recombinant GM-CSF, sargramostim, first attempts at boosting the innate immune system are being made. Therefore, it is likely to be only a pioneering agent that may provide the proof of concept only to be succeeded ...
22
Differential patterns of histone acetylation in inflammatory bowel diseases
... to its anti-proliferative action, an effect on histone acety- lation could be associated with its therapeutic effects. For example, in human umbilical vein endothelial cells (HUVEC), induction of tissue-type plasminogen ...
12
Comparison of Psychological Factors in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Diseases
... The study appertained to patients who underwent initial colonoscopy at two teaching hospitals of Babol University of Medical Sciences from March 2012 to November 2013. The case notes of all the patients were screened by ...
8
Towards therapeutic disease control in inflammatory bowel diseases
... Also, it has been shown that complete mucosal healing in patients with early-stage Crohn’s disease is associated with significantly higher steroid-free remission rates 4 years after th[r] ...
172
Thrombosis in inflammatory bowel diseases: what’s the link?
... Several studies, in UC and CD patients, reported both quantitative and qualitative alterations of many coagulation enzymes, some of which are also considered acute-phase reactants. This includes elevation of circulating ...
9